The fund seeks to enable researchers to make leaps rather than incremental advances in the natural sciences and engineering.

A research team at Leibniz-HKI has described a new enzyme that renders the highly toxic molecule malleicyprol harmless.

Researchers have developed a machine learning model called DreaMS, which significantly accelerates the analysis of previously unknown molecules. The study is published in Nature Biotechnology. The ...

The highly ordered, evenly spaced spikes of a cicada wing can be modified to act as an optical metamaterial, using their tiny ...

Ocean Optics reports on how spectroscopy revolutionizes research by utilizing light to analyze materials, improving accuracy ...

Google spent much of the past year hustling to build its Gemini chatbot to counter ChatGPT, pitching it as a multifunctional AI assistant that can help with work tasks or the digital chores of ...

Cholera is a deadly bacterial disease that kills about 95,000 people every year. Vibrio cholerae bacteria infect cells in the small intestine, which the bacteria can do in part due to their ...

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...

New simulations reveal that the Milky Way’s odd split between two chemically distinct groups of stars isn’t a universal ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related ...